Scientific Program

Please find here the scientific program for the 2024 ESVONC congress in Bucharest. 

There will be no live streaming.  

The Nurses program on Friday 24th & Saturday 25th May is visible under the separate tab in the top menu.

 

VETERINARIANS' PROGRAM

The Grand Hotel Bucharest will be the venue for the 2024 ESVONC Congress.

 

Wednesday 22nd May - Residents' Workshop

Residents' Workshop
15.00-15.45 Making the grade: A review of tumor grading systems in veterinary onco-pathology for common to rare tumor types  Giancarlo Avallone 
15.45-16.30 Going above and beyond: How may an individual patient's tumor be analyzed and reported in the future? Is there such a thing as personalized pathology? Giancarlo Avallone 
16.30-17.00 COFFEE BREAK  
17.00-17.45 Targeted therapies and iNKT cells: Innovative Engineering in Human and Canine Immunotherapy to meet Ever-Emerging Challenges in Cancer Care  Nicola Mason
17.45-18.15 Targeted therapies in Cancer Management: Monoclonal antibodies and checkpoint inhibition harness immune power to eliminate cancer Nicola Mason

 

Thursday 23rd May - Main program

08.00-09.00 REGISTRATION OPENS  
08.45-09.00 Welcome ESVONC to Bucharest! Anca Cristea

RADIATION THERAPY
Session supported by Varian Medical Systems

09.00-09.30 Introduction and General Principles and Limitations about abdominal RT Valerie Poirier
09.30-10.15 Abdominal SBRT and hypofractionation in humans – possible implications for animal radiotherapy Nuno Pimentel MD
10.15-10.45 COFFEE BREAK  
10.45-11.15 Abdominal RT in veterinary practice : genito-urinary and other indications Michael Nolan
11.15-11.45 ASAC the Zurich Experience  Carla Rohrer 
11.45 - 12.15

PANEL DISCUSSION chaired by Dr Valerie Poirier

All speakers
12.15-14.15 Lunch & Poster Session  
14.15-14.45

Sponsored talk by Varian (TBC)

 
RT Abstracts
15.00-15.15 Improvement of neurodisability scores in dogs with intracranial neoplasia treated with two randomly assigned radiation protocols Felicitas Czichon
15.15-15.30 Acute toxicity associated with a daily 5-fraction stereotactic radiation therapy protocol for confirmed or MRI-presumed canine intracranial meningioma James Elliott
15.30-15.45 Preliminary insights from quantitative analysis of pituitary tumour response to definitive radiotherapy in dogs: comparison of three measurement methods Tommaso Pilla
15.45-16.00 A cyclical, palliative-intent hypofractionated radiotherapy protocol (‘Quad-shot’) for the treatment of canine nasal tumours Ines Cabral
16.00-16.30 COFFEE BREAK  
RT Abstracts
16.30-16.45 Can pre-treatment biopsy characteristics predict early treatment failure in feline nasal lymphoma treated with radiation therapy? Valerie Poirier
16.45-17.00 Comparison of two radiotherapy protocols for the palliative treatment of canine nasal adenocarcinoma delivered at a single institution Alison Hayes
17.00-17.15 Efficacy and tolerance of short cycles of palliative radiotherapy in advanced anal sac adenocarcinomas in dogs Mario Militi
17.15-17.30 Long Term Follow-up of dogs with Anal Sac Gland Carcinoma (ASGC) Receiving a Moderate Total Dose 10 Fraction Adjuvant Radiation Protocol 32-36 Gy Sarah L Mason
17.30-18.00

ESVONC RESEARCH FUND PRESENTATION

ESVONC CRF Committee
19.00-21.00

Welcome Reception in Bucharest!

venue: PALACE OF THE PARLIAMENT (Izvor street, no. 2-4)

kindly sponsored by

 Hill's Pet Nutrition & Varian Medical Systems

    

 

 

Friday 24th May - Main Program

08.00-09.00

REGISTRATION

Breakfast round table DeepscanDx (TBC)

 
TARGETED THERAPIES
09.00-09.45 Comparative approaches to improve efficacy and availability of adoptive cell therapies for canine cancer patients Nicola Mason
09.45-10.30 The hunt for correlative biomarkers of immunotherapeutic response - knowing who will respond before treatment Nicola Mason
10.30-11.00 COFFEE BREAK  
11.00-11.45 Immune Checkpoint inhibition: The human experience and Pathways to Veterinary Applications David Vail
11.45-12.30 Novel treatments of metastatic solid tumors: from oligometastatic to polymetastatic states David Vail
12.30-13.00 PANEL DISCUSSION All speakers
13.00-14.30 Lunch  
13.00-14.30

Radiation Oncology Specialty Seminar (for ECVDI RO and ECVIM RO only): 

Machine and Patient-Specific Quality Control in Radiotherapy: Technical and Physical Aspects, and Impact on Daily Clinical Practice and Complication-Free Tumor Control

Sergejs Unterkirhers
Oral Abstracts
14.30-14.45 Tonsillar squamous cell carcinoma in 10 dogs treated with definitive-intent radiation therapy – preliminary data Ana Rejec JenĨek
14.45-15.00 Radiation therapy on macroscopic thyroid tumors: a retrospective study Carlotta Marie Ahrens
15.00-15.15 Prevalence, distribution and prognostic impact of metastatic site in canine patients affected by splenic hemangiosarcoma Chiara Catalucci
15.15-15.30 Vinorelbine for the treatment of histiocytic sarcoma: clinical response and toxicity profile in 18 dogs Nina Vigevani
15.30-16.00 COFFEE BREAK  
16.00-16.30

SPONSORED TALK by CanCan Diagnostics

 
Oral Abstracts
16.30-16.45 Pilot study investigating the intravenous administration of monomeric L-asparaginase to dogs with multicentric lymphoma Vittorio Botta
16.45-17.00 Electrochemotherapy for the treatment of canine prostatic carcinoma: preliminary results in nine dogs Filomena Assunta Amato
17.00-17.15 Current recommendations for sentinel lymph node biopsy in canine malignancies: a survey study Lavinia Elena Chiti
17.15-17.30 Evaluation of time to neutropenic nadir in dogs receiving carboplatin: a multicentric retrospective study Jose Alvarez Picornell
18.00-... Evening on your own!  

 

Saturday 25th May - Main Program

08.00-09.00 REGISTRATION  
Artificial Intelligence Lectures
09.00-09.45 Artificial Intelligence: What is AI? And what is its current and future relevance to human and veterinary biomedical sciences? Kevin Wells
09.45-10.30

AI in veterinary oncology: Tumor grading, staging and treatment

Kevin Wells
10.30-11.00 COFFEE BREAK  
11.00-11.45 Artificial intelligence in diagnostic imaging: reality or promise? Tomasso Banzato
11.45-12.30 AI in Radiation Oncology Michael Nolan
12.30-13.00 PANEL DISCUSSION chaired by Dr Nicola Mason All speakers
13.00-15.00 Lunch  
     
14.00-15.00 ANNUAL GENERAL MEETING (AGM) ESVONC members
15.00-15.30

SPONSORED TALK by DeepscanDx (title TBC)

 
Oral Abstracts
15.30-15.45 Characterization of the fecal microbiota in dogs with mast cell tumours and comparison with healthy dogs Catarina Aluai-Cunha
15.45-16.00 Multimodal characterization of canine perivascular wall and peripheral nerve sheath tumors Houria Ech-Cherif
16.00-16.15 Looking forward to 2025 ESVONC @ PORTO Presentation  
16.15-16.45 COFFEE BREAK  
Oral Abstracts
16.45-17.00 Molecular characterization of canine FSA and MFS using spatially defined transcriptomics and proteomics Daniel Fuchs
17.00-17.15 Trametinib inhibits growth of canine oral squamous cell carcinoma Santiago Peralta
17.15-17.30 Comparison of various electrochemotherapy protocols for the treatment of feline cutaneous squamous cell carcinoma Nicolas Diop
17.30-17.45 Microwave ablation in veterinary oncology : a pilot study in 23 patients David Sayag
17.45-18.00 Comparison of MOPP versus LOPP for first-line treatment of canine multicentric T-cell or hypercalcemic lymphoma Ashley Smith
20.00-...

ESVONC's GALA DINNER

venue: LINEA / CLOSER TO THE MOON

kindly sponsored by